Cite
Absence of Post-Transplantation Lymphoproliferative Disorder after Allogeneic Blood or Marrow Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis.
MLA
Kanakry, Jennifer A., et al. “Absence of Post-Transplantation Lymphoproliferative Disorder after Allogeneic Blood or Marrow Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis.” Biology of Blood & Marrow Transplantation, vol. 19, no. 10, Oct. 2013, pp. 1514–17. EBSCOhost, https://doi.org/10.1016/j.bbmt.2013.07.013.
APA
Kanakry, J. A., Kasamon, Y. L., Bolaños-Meade, J., Borrello, I. M., Brodsky, R. A., Fuchs, E. J., Ghosh, N., Gladstone, D. E., Gocke, C. D., Huff, C. A., Kanakry, C. G., Luznik, L., Matsui, W., Mogri, H. J., Swinnen, L. J., Symons, H. J., Jones, R. J., & Ambinder, R. F. (2013). Absence of Post-Transplantation Lymphoproliferative Disorder after Allogeneic Blood or Marrow Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis. Biology of Blood & Marrow Transplantation, 19(10), 1514–1517. https://doi.org/10.1016/j.bbmt.2013.07.013
Chicago
Kanakry, Jennifer A., Yvette L. Kasamon, Javier Bolaños-Meade, Ivan M. Borrello, Robert A. Brodsky, Ephraim J. Fuchs, Nilanjan Ghosh, et al. 2013. “Absence of Post-Transplantation Lymphoproliferative Disorder after Allogeneic Blood or Marrow Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis.” Biology of Blood & Marrow Transplantation 19 (10): 1514–17. doi:10.1016/j.bbmt.2013.07.013.